Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation. - Hummel M; Hielscher T; Emde-Rajaratnam M; Salwender H; Beck S; Scheid C; Bertsch U; Goldschmidt H; Jauch A; Moreaux J; Seckinger A; Hose D (JCO precision oncology, 2024)